# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA656398 | Functional | Concentration that causes morphological changes in noninfected CEM-SS cells | Homo sapiens | 2 | ALA1135645 | cell-based format | Scientific Literature | |
2. | ALA686037 | Functional | In Vitro Anti-HIV activity in CEM cells | Human immunodeficiency virus 1 | 1 | ALA1135645 | organism-based format | Scientific Literature | |
3. | ALA693285 | Functional | In vitro anti Neoplastic Activity against Adriamycin resistant Human Breast adenocarcinoma MCF7-Adr Cell lines | Homo sapiens | 3 | ALA1135645 | cell-based format | Scientific Literature | |
4. | ALA693288 | Functional | In vitro anti Neoplastic Activity against Human Breast adenocarcinoma MCF-7 Cell lines | Homo sapiens | 3 | ALA1135645 | cell-based format | Scientific Literature | |
5. | ALA694826 | Functional | In vitro anti Neoplastic Activity against Human non small cell lung carcinoma A549 Cell lines;Value ranges from (3-10). | Homo sapiens | 1 | ALA1135645 | cell-based format | Scientific Literature | |
6. | ALA695825 | Functional | In vitro anti Neoplastic Activity in Human Colon adenocarcinoma HT-29 Cell lines;Value ranges from (3-30). | Homo sapiens | 1 | ALA1135645 | cell-based format | Scientific Literature | |
7. | ALA697107 | Functional | In vitro anti Neoplastic Activity against Human ovarian carcinoma A121 Cell lines;Value ranges from (1-30) | Homo sapiens | 1 | ALA1135645 | cell-based format | Scientific Literature | |
8. | ALA701190 | Functional | In vitro inhibition of of AdoMetDC derived from L1210 Murine Leukemia Cells. | Mus musculus | 4 | ALA1135645 | cell-based format | Scientific Literature | |
9. | ALA707518 | Functional | In vitro Anti Neoplastic Activity against L1210 murine leukemia Cell lines | Mus musculus | 6 | ALA1135645 | cell-based format | Scientific Literature | |
10. | ALA848177 | Functional | Differential selectivity as the ratio of TC50 value to that of EC50 value. | 1 | ALA1135645 | assay format | Scientific Literature | ||
11. | ALA816587 | Functional | Mean survival days against T.b. brucei LAB 110 EATRO tested in mice administration at 100 mg/kg for 7 days. | Trypanosoma brucei brucei | 1 | ALA1135645 | organism-based format | Scientific Literature | |
12. | ALA816588 | Functional | Mean survival days against T.b. brucei LAB 110 EATRO tested in mice administration at 25 mg/kg for 7 days. | Trypanosoma brucei brucei | 1 | ALA1135645 | organism-based format | Scientific Literature | |
13. | ALA816589 | Functional | Mean survival days against T.b. brucei LAB 110 EATRO tested in mice administration at 50 mg/kg for 7 days. | Trypanosoma brucei brucei | 1 | ALA1135645 | organism-based format | Scientific Literature | |
14. | ALA816590 | Functional | Mean survival days against T.b. peritoneal administration at 10 mg/kg for 3 days. | Trypanosoma brucei brucei | 2 | ALA1135645 | organism-based format | Scientific Literature | |
15. | ALA816591 | Functional | Mean survival days against T.b. peritoneal administration at 25 mg/kg for 3 days. | Trypanosoma brucei brucei | 2 | ALA1135645 | organism-based format | Scientific Literature | |
16. | ALA816592 | Functional | Mean survival days against T.b. peritoneal administration at 50 mg/kg for 3 days. | Trypanosoma brucei brucei | 2 | ALA1135645 | organism-based format | Scientific Literature | |
17. | ALA816593 | Functional | Mean survival days against T.b. rhodesiense KETRI 243 tested in mice after intra peritoneal administration at 100 mg/kg for 7 days. | Trypanosoma brucei rhodesiense | 1 | ALA1135645 | organism-based format | Scientific Literature | |
18. | ALA817226 | Functional | Mean survival days against T.b. rhodesiense KETRI 243 tested in mice after intra peritoneal administration at 25 mg/kg for 7 days. | Trypanosoma brucei rhodesiense | 1 | ALA1135645 | organism-based format | Scientific Literature | |
19. | ALA817227 | Functional | Mean survival days against T.b. rhodesiense KETRI 243 tested in mice after intra peritoneal administration at 50 mg/kg for 7 days. | Trypanosoma brucei rhodesiense | 1 | ALA1135645 | organism-based format | Scientific Literature | |
20. | ALA813524 | Functional | In vitro anti trypanosomal activity against Trypanosomal 110 (EATRO)strain | Trypanosoma brucei brucei | 6 | ALA1135645 | organism-based format | Scientific Literature |